Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rett syndrome
Biotech
Neurogene acts as gene therapy puts person in critical condition
Neurogene has dropped plans to keep studying the high dose of its Rett syndrome gene therapy amid safety concerns.
Nick Paul Taylor
Nov 18, 2024 8:33am
Acadia makes $100M profit from $150M pediatric voucher sale
Nov 6, 2024 9:36am
A brain parasite has been turned into drug delivery system
Jul 29, 2024 2:55pm
Taysha links gene therapy to motor gains in small Rett study
Jun 18, 2024 11:44am
FDA picks Denali, Neurogene and more for rare disease program
Jun 4, 2024 2:51pm
Anavex stock sinks 30% as lead asset fails in Rett syndrome
Jan 2, 2024 12:08pm
